FIELD: medicine.
SUBSTANCE: invention refers to medical radiology and can be used for prevention of acute radiation disease caused by external radiation. Proposed is the use as an agent for prevention of acute radiation disease of tizanidine-5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazol hydrochloride in the form of legal drugs "Tizanidine Teva", "Sirdalud" and "Tizalud". Previously these preparations based on tizanidine used in medicine as antispastic agents to reduce spasticity and convulsive reaction of skeletal muscles of various aetiologies.
EFFECT: technical result is ensuring radiation protection in conditions of total short-term gamma radiation in doses of about CD90/30 comparable with the efficiency of the prototype means (cystamine), in reduction in 50-100 times the effective dose of a radioprotector and in faster development of the radiation-proof effect 4-6 times.
1 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING AND TREATING ACUTE RADIATION INJURY | 2021 |
|
RU2770991C2 |
| METHOD OF PROTECTING ANIMALS FROM HIGH-DOSE IONIZING RADIATION | 2019 |
|
RU2701155C1 |
| AGENT FOR THE TREATMENT OF RADIATION SICKNESS | 2022 |
|
RU2797586C1 |
| RADIOPROTECTOR | 2010 |
|
RU2428192C1 |
| AGENT POSSESSING SELECTIVE RADIO- AND CHEMOPROTECTIVE ACTION | 2007 |
|
RU2339386C1 |
| AGENT FOR EARLY THERAPY OF RADIATION DAMAGES | 1998 |
|
RU2164139C2 |
| METHOD OF APPLYING VEGETABLE POLYSACCHARIDE AS RADIOPROTECTOR AND STIMULATOR OF COLONY FORMATION OF SPLEEN STEM CELLS IN IRRADIATED ANIMALS | 2013 |
|
RU2537033C1 |
| METHOD OF PHARMACOLOGICAL PROTECTION FROM IONIZING RADIATION | 2017 |
|
RU2663465C1 |
| METHOD FOR PREVENTING AND TREATING ACUTE RADIATION INJURY | 2019 |
|
RU2694222C2 |
| METHOD FOR REDUCING UNDESIRABLE SIDE EFFECTS OF B-190 PREPARATION | 2013 |
|
RU2575576C2 |
